Skip to main content
Clinical Trials/NCT05941728
NCT05941728RecruitingNot Applicable

Persea Americana for Total Health (PATH)-2

University of Illinois at Urbana-Champaign1 site in 1 country45 target enrollmentStarted: July 11, 2023Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
45
Locations
1
Primary Endpoint
Concentration of fecal bile acids

Study Overview

Brief Summary

The goal of this clinical trial is to learn about the effects of avocado consumption on gastrointestinal health in adults with overweight and obesity. The main questions is aims to answer are:

How does avocado consumption affect the gut microbiome? How does avocado consumption affect thinking? Are there connections between the microbiome and cognition? Participants will be asked to eat provided meals with and without avocados for three 4-week periods. At the end of each 4-week period, participants will be asked to provide stool samples and complete computer games that assess thinking and memory.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Basic Science
Masking
Single (Investigator)

Eligibility Criteria

Ages
25 Years to 74 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Participants must be between the ages of 25 and 74 years old
  • •BMI ≥ 25 kg/m2
  • •Ability to drop off fecal sample within 15 minutes of defecation
  • •20/20 or corrected vision

Exclusion Criteria

  • •Avocado allergy or intolerance
  • •Food allergies or intolerances
  • •Prior diagnosis of liver or gastrointestinal disease (primary biliary cirrhosis or gallbladder disease, chronic constipation, diarrhea, Crohn's disease, celiac disease, ulcerative colitis, irritable bowel syndrome, diverticulosis, stomach or duodenal ulcers), diabetes, hepatitis, HIV, or cancer
  • •Women that are pregnant, have given birth in the previous 12 months or are lactating
  • •Individuals that smoke, use tobacco, abuse drugs, or consume > 2 alcoholic beverages per day.
  • •> 5% weight change in the past month or > 10% change in the past six months
  • •Oral antibiotics during the previous 6 weeks.
  • •Currently taking lipid-lowering medications, oral hypoglycemic agents, or insulin.
  • •History of malabsorptive or restrictive bariatric surgeries (e.g., gastric bypass, sleeve gastrectomy, adjustable gastric band) or gall bladder removal surgery.
  • •Are unable to consume the experimental meals/snacks.
  • •Allergic to latex
  • •Concurrent enrollment in another dietary, exercise, or medication study

Arms & Interventions

Fiber + Oil

Active Comparator

The active comparator will have a snack that mimics the fiber and fatty acid composition found in avocados and will be consumed daily for 4 weeks.

Intervention: Oil + Fiber (Other)

Standard American Diet

Sham Comparator

The sham comparator contains foods and beverages of a standard American diet and will be consumed daily for 4 weeks.

Intervention: Average American Diet (Other)

Avocado

Experimental

The experimental treatment will contain an avocado. Avocados will be consumed daily for 4 weeks.

Intervention: Avocado (Other)

Outcomes

Primary Outcomes

Concentration of fecal bile acids

Time Frame: 4 weeks

Fecal bile acid concentrations using HPLC in avocado and active comparator vs. control,

Fecal microbial genes

Time Frame: 4 weeks

Microbial genes involved in short-chain fatty acids and secondary bile acid synthesis measured using metagenomic sequencing

Fecal microbial species

Time Frame: 4 weeks

Feacalibacterium spp., bacteria capable of producing SCFA and secondary bile acid synthesis measured using metagenomic sequencing

Concentration of fecal SCFA

Time Frame: 4 weeks

Fecal SCFA concentrations using GC-MS in avocado and active comparator vs. control,

Secondary Outcomes

  • Subjective gastrointestinal tolerance via questionnaire(4 week)
  • Cognitive function(4 weeks)
  • Digestive health using stool records/Bristol Stool Scale(4 week)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Hannah Holscher

Associate Professor

University of Illinois at Urbana-Champaign

Study Sites (1)

Loading locations...

Similar Trials